Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 15Squamous Cell Carcinoma of Head and Neck 14Neoplasms 8Colonic Neoplasms 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Squamous Cell 4Carcinoma 4Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Thyroid Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Neurofibromatosis 2 1

Interventions

Fulvestrant 2tivozanib 1ribociclib 1palbociclib 1niraparib 1lorlatinib 1exemestane 1encorafenib 1cemiplimab 1binimetinib 1abemaciclib 1Tamoxifen 1STX-478 1Metformin 1Letrozole 1Imlunestrant 1Cetuximab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Cetuximab × 30 days × Clear all
NCT04800822 2026-06-04

PF-07284892 in Participants With Advanced Solid Tumors

Pfizer

Phase 1 Terminated
53 enrolled
CNSGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neurofibromatosis 1, Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡